SEC Form 4 · accession 0001682852-26-000141
Moderna, Inc. · MRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Hoge
Officer — President
Period of report
Jul 15, 2026
Accepted (ET)
Jul 16, 2026 · 4:45 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001682852
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 15, 2026 | M | 37,226 | $19.15 | A | 1,521,074 | D | |
| Common Stock | Jul 15, 2026 | M | 16,110 | $19.15 | A | 1,537,184 | D | |
| Common Stock | Jul 15, 2026 | S | 53,336 | $67.60 | D | 1,483,848 | D | |
| Common Stock | holding | — | — | — | 4,116 | I | By Valhalla, LLC | |
| Common StockF2 | holding | — | — | — | 151,933 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $19.15 | Jul 15, 2026 | M | 37,226 | D | — | Aug 10, 2026 | Common Stock | 37,226 | 0 | D |
| Stock Option (Right to Buy)F3 | $19.15 | Jul 15, 2026 | M | 16,110 | D | — | Aug 10, 2026 | Common Stock | 16,110 | 0 | D |
Explanation of responses
- F1The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025.
- F2These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- F3This option is fully vested and exercisable.